Image provided by: Texas A&M University
About The Battalion. (College Station, Tex.) 1893-current | View Entire Issue (March 24, 1994)
HEY YOU! AGGIE GRADUATE STUDENTS Get Ready SPRING FLING IS RIGHT AROUND THE CORNER It’s a Celebration for Graduate Students, Friends and Families March 26, 1994 On campus at the Grove (Shine) or DeWare (Rain) From 12:00 (noon) to 5:00 p.m. Sponsored by Graduate Student Council ALLIED HEALTH PROFESSIONALS Discover a challenging future with opportunities to advance. Serve your country while you serve your career with: • great pay and benefits • normal working hours • complete medical and dental care • 30 days vacation with pay per year Find out how to qualify as an Air Force professional. Call USAF HEALTH PROFESSIONS TOLL FREE 1-800-423-USAF r cc o US citizens with a 3.0 GPR are eligible Informational MEETINGS Wed. March 2, 10:15am fhur. March 10, 4:00pm 251 Bizzell flail West Study Abroad Programs, 161 Bizzell Hall West, 845-0544 ITESM Oportunidades de trabajo en Mexico Institute Tecnologico y de Estudios Superiores de Monterrey Institucion: Sistema ITESM Puesto: Profesor-consultor-investigador en cualquiera de los 26 campus del Sistema ITESM Perfil: • Grado de Maestria o Doctorado • Disponibilidad para agosto de 1994 • Espafiol indispensable Areas: Administracion, Comercio Internacional, Computacion, Contabilidad, Finanzas, Economia, Educacion, Estadistica, Idiomas, Lingiiistica, Ingenieria Industrial, Matematicas, Mercadotecnia, Ingenieria de Sistemas y Sistemas de Informacion Lugar: 510 RUDDER TOWER Texas A&M University Dia: Jueves 24 de Marzo Mora: 6:15 p.m. Para mayor informacion comunicarse con Felipe Zambrano - 764-7534 SiaFTorci Qpgra I>Qusg Presents JIMMIE DAEE GILMORE Voted ' ’ of the year, and best folk act in 1994 by the Austin Music Awards; voted country artist of the year in both 1992 and 1993 by Rolling Stone magazine. LIVE IN-STORE PERFORMANCE Thursday March 24 - 5:00pm Marooned Records 1 1 O College Main 846-001 7 Page 14 The Battalion Thursday, March 24,19 Tubularmcm By Boomer Cardinale Trading cards Tb help police improve relation with city youth The Associated Press MICH/ s BELINt HEATH TONI < Bartholomew by lialvin Eisenhower By Alex FORT WORTH — In a city pup by skyrocketing violence belweti youth gangs, authorities are tin hard to improve their relations!]; with kids. One of the newest proposal is;! create "police trading cards.” Police say they hope the cards« ! elevate police to "hero status" in it minds of youths — particularly]; neighborhoods now troubled I guns, drugs and gangs. "I wouldn’t say we’re looking! the trading cards primarily beejus* of the gang problem in Fort Wortk We’ve been debating it for seven years, even before the gang situatio: was as pronounced as it is now.Iiiii timely though,” Lt. Greg Bradlt said Wednesday. "And actually, we hope the card will be helpful for the kids who aren; involved in crime as well as fortb who are, and maybe remove the barn ers that may be there between som kids and officers." Bradley and Chief Thomas Wind ham took the idea to the City Count on Tuesday. "It’s not a done deal. We wamcj to make sure we had the councili blessing to proceed further, and: don’t think we got a yes ornoom: yet. We’re waiting to embark onii, but I expect we’ll get the go-ahead, Bradley said. Dr. . . , r , ■dream. I ne idea ol police trading cards thinkii isn’t new. Other cities in the Dallas- Fort Worth area — including Arling Bhe co ton, Cleburne, DeSoto. Mesquite anc jtuden University Park — have tried thecatis jormit as a means to link kids with officers Violence Continued from Page 1 timony before a commission investi gating the mosque massacre, Barak said the Palestinian bystander appar ently died from gunfire by the guerril las. Al-Ahli hospital in Hebron said an army bullet killed Hunduq Zahdeh, 34, who was five months' pregnant. The military had no immediate re sponse to a statement by Mohtasseb Children’s Hospital condemning sol diers for firing from the roof and tromping repeatedly through wards holding 32 children despite their ob vious fright. "The shooting continued all night. The children were very scared and cried all night. They could not sleep," said the hospital’s director, Dr. Hisham Abu Gharbiyah. At a Jerusalem news conference, af the :ation yard r PLO negotiator Saeb Erekat sharpkBthat 1 criticized Prime Minister Yitzhak Ri decadt bin. ffithe eff "Rabin talks a lot about peace i.'i hous English, but his orders in Hebrew ti! ^ tui his troops is to continue their terro: tl0n 1 campaign and massacres against civil ' <)VC ’ 1 ians," he said. . mrenc thems and c DepoProvera occur and, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. Contraceptive Injection (sterile medroxyprogesterone acetate suspension, USP) 2. Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the normal rate of age-related bone mineral loss. WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an i muscular Injection (a shot) in the buttock or upper arm once every 3 months. To con intra- , . . . - . - continue our contraceptive protection, you must return for your next injection promptly at the end of o months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle., DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur. 3. Cancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no Increased overall risk of developing cancer of the breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-care provider. 4. Accidental Pregnancy HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for icy Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months) is very low. While there have been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are rare. If you think you may have become pregnant while using DEPO-PROVERA for con- >wn. Ito be they f segre, will b to CO] outsid Stui expose pie an- reason rural n 0 traception, see your health-care provider as soon as possible. control available, i nis means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other con traceptive methods and give you the information you need in order to decide which contra ceptive method is the right choice for you. 5. Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. JOSI ELCI The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-PROVERA CONTRACEPTIVE INJECTION? PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY IN THE FIRST YEAR OF CONTINUOUS USE Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness ot breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness In the lower abdominal area; or persistent pain, pus, or bleeding at the injection site. Method Lowest Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant*) 0.3 0.3 Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) _ 3 Combined 0.1 Progestogen only 0.5 - IUD 3 Proqestasert 2.0 Copper T 380A 0.8 - Condom (without spermicide) 2 12 Diaphragm (with spermicide) 6 18 Cervical Cap 6 18 Withdrawal 4 18 Periodic abstinence 1 -9 20 Spermicide alone 3 21 Vaginal Sponge Used before childbirth 6 18 Used after childbirth 9 28 No method 85 85 Source: Trussell et at; Obstet Gyncol 76:558,1990 WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year. Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or approximately 2.75 pounds per year. 2. Other Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, and hot flashes. Other problems were reported by very few ot the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack ot return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss ' alth-c Cues credit c; north-e, feel the energizt Was' come uj place w dodginj made hi dealers ’ spraying them with your health-care provider. SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA CONTRACEPTIVE INJECTION? WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Missed Periods Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you think you might be pregnant, have any vaginal bleeding without a known reason, have had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in your legs, have problems with your liver or liver disease, or are allergic to DEPO- PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your doctor if you are taking any prescription or over-the-counter medications or if During the time you are using DEPO-PROVERA for contraception, you may skip a pei or your periods may stop completely. If you have been receiving your DEPO-PROVI iriod, VERA injections regularly every 3 months, then you are probably not pregnant. However, If you think that you may be pregnant, see your health-care provider, you have a family history of breast cancer; an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches; asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a history of depression. 2. Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3. Drug interactions Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given during the same time. WHAT IF I WANT TO BECOME PREGNANT AFTER USING DEPO-PROVERA CONTRACEPTIVE INJECTION? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become preg nant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become pregnant will do so in about 18 months after their last injection. The length of time you use DEPO-PROVERA has no effect on how long it takes you to become pregnant after you stop using it. 4. Nursing Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harm ful effects have been found in these children. DEPO-PROVERA does not prevent the breasts from producing milk, so it can be used by nursing mothers. However, to minimize the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception. WHAT ARE THE RISKS OF USING DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contra ception is a change in their normal menstrual cycle. During the first year of using DEPO- PROVERA, you might have one or more of the following changes: Irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at ail Unusually heavy or continuous bleeding, however, is not a usual effect of DEPO-PROVERA —> =* *V| IS * -*-—*-* - ■ ■ • HOW OFTEN DO I GET MY SHOT OF DEPO-PROVERA CONTRACEPTIVE INJECTION? The recommended dose of DEPO-PROVERA is 150 mg every 3 months given in a single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant at the time of the first injection, it is important that the injection be given only during the first 5 days after the beginning of a normal menstrual period. If used following the delivery of a child, the first injection of DEPO-PROVERA should be given within 5 days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are breast-feeding. If you wait longer than 3 months between injections, or longer than 6 weeks after childbirth, your health-care provider should determine that you are not pregnant before giving you your injection of DEPO-PROVERA. and if this ha| use of DEPO-PROVI ods completely. In clinic ed no menstrual bleedim reported no menstrual bleeding after With continued having peri- studied report- after 1 year of use, and 68% of the women studied _____ ___,_ years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not Caution: Federal law prohibits dispensing without a prescription. You must see a doctor to receive a prescription. Asa ■eel ob] jyfatt M rations whetha ‘Qterpn Uowevf Utd wc, ate it, ane’s o he p u b ^oup, Popular We ] ‘Vhich •vith be Upjohn The Upjohn Company Kalamazoo, Ml 49001, USA CB-2-S USJ 9529.00